Blue Jet Healthcare has scheduled an Extra-Ordinary General Meeting (EGM) on June 17, 2026, to seek shareholder approval for raising funds aggregating up to ₹10,000 million. The company proposes to issue securities, including fully paid-up Equity Shares, fully or partly convertible debentures, or other equity-linked instruments, through one or more tranches via preferential issues, private placements, or Qualified Institutions Placements (QIP).

The fundraising proceeds are intended for growing the existing business through product development, meeting long and short-term working capital requirements, funding capital expenditure, and pre-payment or repayment of outstanding borrowings. The board, at its meeting held on May 25, 2026, approved the proposal, which will be placed before shareholders as a special resolution. The company stated that the exact price, proportion, and timing of the issue will be determined by the board or a duly constituted committee in accordance with applicable regulations.

EGM and Voting Details

The EGM will be held on Wednesday, June 17, 2026, at 11:00 AM (IST) through Video Conferencing (VC) or Other Audio-Visual Means (OAVM). The remote e-voting period commences on June 14, 2026, at 9:00 AM and concludes on June 16, 2026, at 5:00 PM. Shareholders holding shares as on the cut-off date of June 10, 2026, are eligible to vote.

The notice specifies that if the issue is made through a QIP, the allotment of securities must be completed within 365 days from the date of passing the special resolution. The pricing of the securities will be determined in accordance with the pricing formula provided under Chapter VI of the SEBI ICDR Regulations, potentially including a discount of not more than 5% on the floor price. M/s. Mehta and Mehta, Company Secretaries, has been appointed as the scrutinizer for the e-voting process.

Pursuant to Regulation 30 of the SEBI (Listing Obligations and Disclosure Requirements) Regulations, 2015, the company has intimated the exchanges regarding the publication of the EGM notice in newspapers, specifically the Financial Express (English) and Navshakti (Marathi). Sweta Poddar, Company Secretary and Compliance Officer, confirmed the dispatch of the notice on May 27, 2026.

Blue Jet Healthcare has made the audio recording of its earnings conference call for the quarter and financial year ended March 31, 2026, available to the public. The recording, held on May 25, 2026, can be accessed via the company's official website. This disclosure complies with Regulation 30 read with Schedule III of the SEBI (Listing Obligations and Disclosure Requirements) Regulations, 2015.

Accessing the Recording

Stakeholders and interested investors can listen to the proceedings of the conference call by visiting the investor relations section of the Blue Jet Healthcare website. The direct link to the audio recording has been provided to ensure transparency and broad access to the financial discussions.

Conference Call Overview

The original conference call was scheduled to discuss the audited standalone financial results for Q4FY26. It featured participation from senior management, including the Managing Director, Chief Operating Officer, and Chief Financial Officer, who provided insights into the company's performance under its contract development and manufacturing organisation (CDMO) business model.

About the Company

Blue Jet Healthcare operates as a specialty pharmaceutical and healthcare ingredient company. It specialises in contrast media intermediates and high-intensity sweeteners, supplying critical intermediates to major global manufacturers such as GE Healthcare, Guerbet, and Bracco. The company also serves multinational clients like Colgate Palmolive (India) Limited and Unilever through long-term contracts.